Alzheimer’s Drug Discovery Foundation — Newsletter

ADDF newsletter on Alzheimer’s drug discovery, prevention research, scientific developments and research foundation news.

1 issueArchived Nov 3, 2026Subscribe at the source

By Alzheimer's Drug Discovery Foundation

Latest issues

Nov 3, 2026
Eli Lilly Licenses SpeechDx Data, Signaling Momentum for Speech-Based Alzheimer's Measures
Our SpeechDx dataset is helping establish speech as a scalable, AI-driven tool for detecting and monitoring Alzheimer's.